U
ENZN

UBS’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

UBS’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$764K Sell
707,964
-7,441
-1% -$9.19K ﹤0.01% 3848
2014
Q2 		$744K Buy
715,405
+12,227
+2% +$11.6K ﹤0.01% 3837
2014
Q1 		$724K Sell
703,178
-5,779
-0.8% -$5.97K ﹤0.01% 3846
2013
Q4 		$822K Sell
708,957
-10,418
-1% -$16K ﹤0.01% 3759
2013
Q3 		$1.21M Buy
719,375
+12,544
+2% +$23.2K ﹤0.01% 3139
2013
Q2 		$1.41M Buy
+706,831
New +$2.07M ﹤0.01% 2928

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS's ENZN Position: Q3 2014 in Review

UBS reduced its ENZON PHARMACEUTICALS INC (ENZN) stake by 1% in Q3 2014, selling an estimated $9.19K and leaving 707,964 shares worth $764K. The position accounts for ﹤0.01% of the portfolio, ranked #3848.

UBS first reported a position in ENZN in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.41M in Q2 2013. 65 funds tracked by Wall St. Rank hold ENZN as of Q3 2014.

  • UBS held 707,964 shares of ENZON PHARMACEUTICALS INC worth $764K as of Q3 2014.
  • UBS sold 7,441 ENZON PHARMACEUTICALS INC shares in Q3 2014, an estimated $9.19K.
  • ENZON PHARMACEUTICALS INC made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3848 holding.
  • UBS first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and has held it in 6 quarters since.
  • UBS's ENZON PHARMACEUTICALS INC position peaked at $1.41M in Q2 2013.
  • 65 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.